Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alfonso López de Sa"'
Autor:
Alfonso López de Sa, Alejandro Pascual, Javier Garcia Santos, Ramiro Mendez, Monica Bellon, Mar Ramirez, Fatima Matute, Cristina del Arco, Aránzazu Manzano, Pluvio Coronado, Antonio Casado, Gloria Marquina
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-8 (2021)
Abstract Background Inflammatory myofibroblastic tumour is an infrequent mesenchymal neoplasia of unknown aetiology and variable behaviour, ranging from rather benign lesions to locally aggressive and even metastatic disease. Its presence has been de
Externí odkaz:
https://doaj.org/article/eb74c971000e4c69ab8118aa51bdca46
Autor:
Rodrigo Sánchez-Bayona, Manuel Alva, Alfonso López de sa, Yolanda Jerez Gilarranz, Ana Sánchez de torre, Pablo Tolosa, Alicia de luna, Sara López-Tarruella, Laura Lema, Fernando Moreno, Isabel Echavarria, Ainhoa Madariaga, Javier Benítez, Blanca Herrero, Macarena Rey, Justo Ortega, Salvador Gámez, Andrea Modrego, Rocío Martín Lozano, Luis Figuero-Pérez, Roberto Jiménez, Marta González Sevilla, Irene González, Marianela Bringas Beranek, María de toro, Tatiana Massarrah, María del Monte-Millán, Marina Pinardo, Luis Manso, Coralia Bueno-Muiño, José Ángel García-Sáenz, Miguel Martín, Eva Ciruelos
Publikováno v:
Cancer Research. 83:P3-01
Introduction Since the approval a decade ago of everolimus in combination with endocrine therapy (ET), the treatment landscape of metastatic breast cancer (mBC) has changed dramatically. Endocrine monotherapy after progression to CDK4/6 inhibitors ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9380e9f8a13c74c4eac93c5e3b4323c5
https://doi.org/10.1158/1538-7445.sabcs22-p3-01-04
https://doi.org/10.1158/1538-7445.sabcs22-p3-01-04
Autor:
Javier Benítez, Alfonso López de Sa, Julia Tejerina-Peces, Carlos Lombardía Gonzalez, Carmen Toledano, Jorge Bartolomé, Carlos Aguado, Jennifer Olalla, Mateo Paz, Mónica Granja, Paloma Flores, Justo Ortega, Gloria Marquina, Aránzazu Manzano, Alicia de Luna, Araceli Priego, Jesús Fuentes-Antrás, Pedro Pérez-Segura
Publikováno v:
International Journal of Cancer
Coronavirus disease 2019 (COVID‐19) pandemic is affecting a high percentage of the population at an unprecedented rate. Cancer patients comprise a subgroup especially vulnerable to this infection. Herein, we present a prospective analysis of epidem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffd3ceeb8899ae358bce405ee46ba98d
https://doi.org/10.1002/ijc.33420
https://doi.org/10.1002/ijc.33420
Autor:
Javier Garcia Santos, Pluvio J. Coronado, Aránzazu Manzano, Mar Ramirez, Antonio Casado, Alejandro Pascual, Gloria Marquina, Ramiro Mendez, Monica Bellon, Fatima Matute, Alfonso López de Sa, Cristina del Arco
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-8 (2021)
World Journal of Surgical Oncology
World Journal of Surgical Oncology
Background Inflammatory myofibroblastic tumour is an infrequent mesenchymal neoplasia of unknown aetiology and variable behaviour, ranging from rather benign lesions to locally aggressive and even metastatic disease. Its presence has been described i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c008b44c75098981c9c3020b88247fc
https://doi.org/10.1186/s12957-021-02438-5
https://doi.org/10.1186/s12957-021-02438-5
Autor:
Alfonso López de Sá, Cristina Díaz-Tejeiro, Elisa Poyatos-Racionero, Cristina Nieto-Jiménez, Lucía Paniagua-Herranz, Adrián Sanvicente, Emiliano Calvo, Pedro Pérez-Segura, Víctor Moreno, Francisco Moris, Alberto Ocana
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-13 (2023)
Abstract Antibody–drug conjugates (ADCs) have emerged as a novel therapeutic strategy that has successfully reached patient treatment in different clinical scenarios. ADCs are formed by an antibody against a specific tumor-associated antigen (TAA),
Externí odkaz:
https://doaj.org/article/c72087b5dfa54ed0aa029fccbd8b25e2
Autor:
Alfonso López de Sa, Alicia de Luna, Jesús Fuentes-Antrás, José A. García-Sáenz, Alberto Ocaña, Fernando Salvador Moreno
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 54, Iss, Pp 160-163 (2020)
Breast, Vol 54, Iss, Pp 160-163 (2020)
Cyclin-dependent kinase inhibitors (CDKIs) and endocrine therapy (ET) are the corner-stone of systemic therapy for patients with hormone-positive (HR+) HER2-negative metastatic breast cancer (MBC). However, limited data exist regarding rechallenge tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2534165b7fda8c9d16a078f726c313d3
https://pubmed.ncbi.nlm.nih.gov/33096323
https://pubmed.ncbi.nlm.nih.gov/33096323
Autor:
Alfonso López de Sá, Alicia de Luna, Mónica Antoñanzas, Vanesa García-Barberán, Fernando Moreno-Anton, Jose A. García-Sáenz
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Background: Hormone receptor-positive, human epidermal growth factor 2-negative advanced breast cancer patients have had a wide range of therapeutical options since the incorporation of targeted therapies alongside classic chemotherapy. However, beca
Externí odkaz:
https://doaj.org/article/9a49bf5b8732493da1bea930052a044e
Autor:
Jesús Fuentes-Antrás, Alicia de Luna, Alfonso López de Sá, Alberto Ocaña, José Ángel García-Sáenz, Fernando Moreno
Publikováno v:
Breast, Vol 54, Iss , Pp 160-163 (2020)
Cyclin-dependent kinase inhibitors (CDKIs) and endocrine therapy (ET) are the corner-stone of systemic therapy for patients with hormone-positive (HR+) HER2-negative metastatic breast cancer (MBC). However, limited data exist regarding rechallenge tr
Externí odkaz:
https://doaj.org/article/95698fb758b5427f9c6c094f9ae51f0a
Autor:
Alfonso Lopez de Sa Lorenzo, Paloma Flores Navarro, Berta Laguna Fonseca, Carmen Toledano Rojas, Alicia de Luna Aguilar, Javier David Benitez Fuentes, Tania Rocha Iñigo, Clara Frick, Richa Shah, Natalia Vidal Cassinello, Alejandro Francisco Jimenez Ortega
Publikováno v:
F1000Research, Vol 11 (2022)
Background: Human bocavirus (HBoV) is a viral pathogen from the genus Bocaparvovirus (family Parvoviridae, subfamily Parvovirinae) discovered in 2005. Most of available literature is about HBoV in children and adults with hematological malignancies a
Externí odkaz:
https://doaj.org/article/5519d9ff57dc4c31830f8a89d7cd6279